brand:
AZZALURE®
manufacturer:
Galderma
active substances:
BOTULINUM TOXIN TYPE A
strength:
125 Speywood units
pack size:
1 X 125 Speywood units/ml Vial
Azzalure® contains botulinum toxin type A, which is a neuromuscular blocker that temporarily relaxes facial muscles. The primary use of Azzalure is for adults under 65 to improve the appearance of glabellar lines (frown lines between the eyebrows) and lateral canthal lines (crow’s feet around the eyes). It works by preventing the release of acetylcholine, a chemical that triggers muscle contractions.
Azzalure is administered as an injection by trained physicians and should only be used for a single treatment session.
As with any botulinum toxin-based product, there are risks associated with Azzalure injections, although not everyone experiences them. Most side effects are temporary and mild to moderate in severity.
Azzalure has been extensively studied for its effectiveness in treating glabellar lines and crow’s feet. In clinical trials, patients reported visible reductions in facial lines within 3 to 4 days of treatment, with peak results typically seen around 14 days post-injection.
Certain medications and other botulinum toxin injections can interact with Azzalure, potentially increasing its effects or side effects.
Check out these alternatives that might suit your needs
View more alternatives from Botulinum Toxins